U.S. market Closed. Opens in 11 hours 31 minutes

TGTX | TG Therapeutics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for TGTX we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is wealthy, Growth is good and Health is passable.

Valuation (31%)

Company Industry
P/E Ratio (TTM) 35.89 -16.22
PEG Ratio (TTM) 1.01 -1.41
P/S Ratio (TTM) 10.60 48.82
P/B Ratio (TTM) 19.34 21.13
P/FCF Ratio (TTM) 54.17 9.38
Price to 5YR AVG Earnings Ratio -13.78 -0.21
Price to 5YR AVG FCF Ratio -21.58 -7.10

Profitability (65%)

Company Industry
ROA (TTM) 23.85% -3.10%
ROE (TTM) -38.21% 24.21%
Net Profit Margin (TTM) 27.60% -1,069.78%
ROIC 5YR AVG 26.07% 16.50%

Growth (65%)

4QTR AVG 3YR AVG 5YR AVG
EPS 103.62% -6.30% 26.18%
Revenue 229.55% 1,433.55% 2,506.46%
Net Income 104.16% -29.05% 12.35%
Cash Flow 97.20% -34.12% 4.05%

Health (60%)

Company Industry
Current Ratio (TTM) 3.58 5.75
Quick Ratio (TTM) 2.83 5.47
D/E Ratio (TTM) 0.58 -15.13
Interest Coverage (TTM) 8.21 3.59
Piotroski F-Score 5 5
Altman Z-Score 7.02 13.47
LTL to 5YR AVG FCF -0.59 0.20
Shares Outstanding Growth 5YR AVG 13.90% 118.86%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙